Viewing Study NCT04517357


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-02-22 @ 7:22 PM
Study NCT ID: NCT04517357
Status: COMPLETED
Last Update Posted: 2025-02-24
First Post: 2020-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module